Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus vs FK506 in OLT for HCC Exceeding Milan Criteria
NCT00554125Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in hepatocellular carcinoma (HCC), sponsored by Fudan University. Status: unknown.
02
Drugs
sirolimus
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00554125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00554125.